Redefining clinical trials: Adopting AI for speed, volume and diversity
IBM Big Data Hub
MAY 6, 2024
Our analysis of the voluntarily reported Form FDA 1572 BMIS database reveals a potential lack of sustainability in the investigator pool, both in the United States (US) and globally (Exhibit 2). By fine-tuning these criteria, protocols can help attract a targeted and more relevant patient group, speeding up recruitment.
Let's personalize your content